Zentalis Pharmaceuticals, LLC Lease Agreements
10 Contracts & Agreements
- Sublease, effective March 6, 2023, between Zentalis Pharmaceuticals, Inc. and L.M. Cohen & Co. LLP Certified Public Accountants, as amended on April 10, 2023 (Filed With SEC on May 10, 2023)
- Lease, effective March 24, 2021, between Zentalis Pharmaceuticals, Inc. and ESRT 1359 Broadway, L.L.C (Filed With SEC on May 17, 2021)
- Lease, effective March 24, 2021, between Zentalis Pharmaceuticals, Inc. and ESRT 1359 BROADWAY, L.L.C (Filed With SEC on March 25, 2021)
- Lease, effective September 30, 2020, between Zentalis Pharmaceuticals, Inc. and TPSC IX, LLC (Filed With SEC on October 2, 2020)
- Agreement for Termination of Lease and Voluntary Surrender of Premises, dated July 27, 2020, by and between Zeno Management, Inc. and ARE-SD-Region NO. 44, LLC (Filed With SEC on July 28, 2020)
- Lease Agreement, dated January 14, 2020, between Zeno Management, Inc. and ARE-SD Region NO. 44, LLC (Filed With SEC on March 6, 2020)
- First Amendment to Lease Agreement, dated December 6, 2018, between the Registrant and BMR-Road to the Cure, LP (Filed With SEC on March 6, 2020)
- Lease Agreement, dated November 12, 2015, between the Registrant and BMR-Road to the Cure, LP (Filed With SEC on March 6, 2020)
- Sublease Agreement, dated September 16, 2019, between Zeno Management, Inc. and Lundbeck La Jolla Research Center, Inc (Filed With SEC on March 6, 2020)
- Lease Agreement, dated April 12, 2019, between Zeno Management, Inc. and G&S Realty 1, LLC (Filed With SEC on March 6, 2020)
